Extracellular matrix alterations in late-onset Fuchs' corneal dystrophy

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 6, 2014, Pages 3700-3708

  Weller, Julia M ^a   Zenkel, Matthias ^a   Schlötzer Schrehardt, Ursula ^a   Bachmann, Bjoern O ^a   Tourtas, Theofilos ^a   Kruse, Friedrich E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Corneal endothelial cells; Descemet's membrane; Extracellular matrix; Fuchs' corneal dystrophy; Pseudophakic bullous keratopathy

Indexed keywords

AGRIN; ALPHA4 INTEGRIN; CELL ADHESION MOLECULE; CLUSTERIN; COLLAGEN TYPE 1; COLLAGEN TYPE 15; COLLAGEN TYPE 16; COLLAGEN TYPE 3; COLLAGEN TYPE 7; FIBRONECTIN; FIBULIN; GLYCOPROTEIN; LAMININ 1; MATRIX METALLOPROTEINASE; MESSENGER RNA; OSTEOPONTIN; PROTEOGLYCAN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; VERSICAN; VITRONECTIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONGENITAL CORNEA DYSTROPHY; CONTROLLED STUDY; DESCEMET MEMBRANE; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; KERATOPATHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CORNEAL ENDOTHELIAL CELLS; DESCEMET'S MEMBRANE; EXTRACELLULAR MATRIX; FUCHS' CORNEAL DYSTROPHY; PSEUDOPHAKIC BULLOUS KERATOPATHY;

AGED; DESCEMET MEMBRANE; DNA; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FUCHS' ENDOTHELIAL DYSTROPHY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; REAL-TIME POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 84902455402     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14154     Document Type: Article

References (58)

1. Gottsch JD, Sundin OH, Liu SH, et al. Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of fuchs corneal dystrophy. Invest Ophthalmol Vis Sci. 2005;46: 1934-1939.
2. Biswas S, Munier FL, Yardley J, et al. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet. 2001;10:2415-2423.
3. Liskova P, Prescott Q, Bhattacharya SS, Tuft SJ. British family with early-onset Fuchs' endothelial corneal dystrophy associated with p. L450W mutation in the COL8A2 gene. Br J Ophthalmol. 2007;91:1717-1718.
4. Mok JW, Kim HS, Joo CK. Q455 V mutation in COL8A2 is associated with Fuchs' corneal dystrophy in Korean patients. Eye. 2009;23:895-903.
5. Sundin OH, Jun AS, Broman KW, et al. Linkage of late-onset Fuchs corneal dystrophy to a novel locus at 13pTel-13q12.13. Invest Ophthalmol Vis Sci. 2006;47:140-145.
6. Sundin OJ, Broman KW, Chang HH, Vito ECL, Stark WJ, Gottsch JD. A common locus for late-onset Fuchs corneal dystrophy maps to 18q21.2-q21.32. Invest Ophthalmol Vis Sci. 2006;47:3919-3926.
7. Riazuddin SA, Eghrari AO, Al-Saif A, et al. Linkage of a mild lateonset phenotype of Fuchs corneal dystrophy to a novel locus at 5q33.1-q35.2. Invest Ophthalmol Vis Sci. 2009;50:5667-5671.
8. Riazuddin SA, Zaghloul NA, Al-Saif A, et al. Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p. Am J Hum Genet. 2010;86: 45-53.
9. Kuot A, Hewitt AW, Griggs K, et al. Association of TCF4 and CLU polymorphisms with Fuchs' endothelial dystrophy and implication of CLU and TGFBI proteins in the disease process. Eur J Hum Genet. 2012;20:632-638.
10. Riazuddin SA, Parker DS, McGlumphy EJ, et al. Mutations in LOXHD1, a recessive-deafness locus, cause dominant lateonset Fuchs corneal dystrophy. Am J Hum Genet. 2012;90: 533-539.
11. Vithana EN, Morgan PE, Ramprasad V, et al. SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Hum Mol Genet. 2008;17:656-666.
12. Riazuddin SA, Vasanth S, Katsanis N, Gottsch JD. Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4. Am J Hum Genet. 2013;93:758-764.
13. Jurkunas UV, Bitar MS, Funaki T, Azizi B. Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy. Am J Pathol. 2010;177:2278-2289.
14. Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. 2002;50:341-351.
15. Azizi B, Ziaei A, Fuchsluger T, Schmedt T, Chen Y, Jurkunas UV. p53-regulated increase in oxidative-stress-induced apoptosis in Fuchs endothelial corneal dystrophy: a native tissue model. Invest Ophthalmol Vis Sci. 2011;52:9291-9297.
16. Bitar MS, Liu C, Ziaei A, Chen Y, Schmedt T, Jurkunas UV. Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2012;53:5806-5813.
17. Matthaei M, Meng H, Meeker AK, Eberhart CG, Jun AS. Endothelial Cdkn1a (p21) overexpression and accelerated senescence in a mouse model of Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2012;53:6718-6727.
18. Czarny P, Kasprzak E, Wielgorski M, et al. DNA damage and repair in Fuchs endothelial corneal dystrophy. Mol Biol Rep. 2013;40:2977-2983.
19. Ziaei A, Schmedt T, Chen Y, Jurkunas UV. Sulforaphane decreases endothelial cell apoptosis in Fuchs endothelial corneal dystrophy: a novel treatment. Invest Ophthalmol Vis Sci. 2013;54:6724-6734.
20. Kim EC, Meng H, Jun AS. Lithium treatment increases endothelial cell survival and autophagy in a mouse model of Fuchs endothelial corneal dystrophy. Br J Ophthalmol. 2013; 97:1068-1073.
21. Repp DJ, Hodge DO, Baratz KH, McLaren JW, Patel SV. Fuchs' endothelial corneal dystrophy: subjective grading versus objective grading based on the central-to-peripheral thickness ratio. Ophthalmology. 2013;120:687-694.
22. Krachmer JH, Purcell JJ, Young CW, Bucher KD. Corneal endothelial dystrophy. A study of 64 families. Arch Ophthalmol. 1978;96:2036-2039.
23. Schlötzer-Schrehardt U, Bachmann BO, Laaser K, Cursiefen C, Kruse FE. Characterization of the cleavage plane in Descemet's membrane endothelial keratoplasty. Ophthalmology. 2011; 118:1950-1957.
24. Kabosova A, Azar DT, Bannikov GA, et al. Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci. 2007;48:4989-4999.
25. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci. 1996;37:997-1007.
26. Akhtar S, Bron AJ, Hawksworth NR, Bonshek RE, Meek KM. Ultrastructural morphology and expression of proteoglycans, betaig-h3-tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy. Br J Ophthalmol. 2001;85:720-731.
27. Gottsch JD, Zhang C, Sundin OH, Bell WR, Stark WJ, Green WR. Fuchs corneal dystrophy: aberrant collagen distribution in an L450 W mutant of the COL8A2 gene. Invest Ophthalmol Vis Sci. 2005;46:4504-4511.
28. Jurkunas UV, Bitar M, Rawe I. Colocalization of increased transforming growth factor beta induced protein and clusterin in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2009;50:1129-1136.
29. Jurkunas U, Bitar MS, Rawe I, Harris DL, Colby K, Joyce NC. Increased clusterin expression in Fuchs' endothelial dystrophy. Invest Ophthalmol Vis Sci. 2008;49:2946-2955.
30. Bourne WM, Johnson DH, Campbell RJ. The ultrastructure of Descemet's membrane. III. Fuchs' dystrophy. Arch Ophthalmol. 1982;100:1952-1955.
31. Zhang C, Bell WR, Sundin OH, et al. Immunohistochemistry and electron microscopy of early-onset fuchs corneal dystrophy in three cases with the same L450W COL8A2 mutation. Trans Am Ophthalmol Soc. 2006;104:85-97.
32. Ljubimov AV, Atilano SR, Garner MH, Maguen E, Nesburn AB, Kenney MC. Extracellular matrix and Na{thorn}, K{thorn}-ATPase in human corneas following cataract surgery. Cornea. 2002;21: 74-80.
33. Kruse FE, Laaser K, Cursiefen C, et al. A stepwise approach to donor preparation and insertion increases safety and outcome of Descemet's membrane endothelial keratoplasty. Cornea. 2011;30:580-587.
34. Schlötzer-Schrehardt U, Dietrich T, Saito K, et al. Characterization of extracellular matrix components in the limbal epithelial stem cell compartment. Exp Eye Res. 2007;85:845-860.
35. Dietrich-Ntoukas T, Hofmann-Rummelt C, Kruse FE, Schlötzer-Schrehardt U. Comparative analysis of the basement membrane composition of the human limbus epithelium and amniotic membrane epithelium. Cornea. 2012;31:564-569.
36. Newsome DA, Gross J, Hassell JR. Human corneal stroma contains three distinct collagens. Invest Ophthalmol Vis Sci. 1982;22:376-381.
37. Melles GR, SundarRaj N, Binder PS, et al. Immunohistochemical analysis of unsutured and sutured corneal wound healing. Curr Eye Res. 1995;14:809-817.
38. Heindl LM, Schlötzer-Schrehardt U, Cursiefen C, Bachmann BO, Hofmann-Rummelt C, Kruse FE. Myofibroblast metaplasia after descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2011;151:1019-1023.
39. Gottsch JD, Bowers AL, Margulies EH, et al. Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy. Invest Ophthalmol Vis Sci. 2003;44:594-599.
40. Tourtas T, Laaser K, Bachmann BO, Cursiefen C, Kruse FE. Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2012;153:1082-1090.
41. Silkensen JR, Schwochau GB, Rosenberg ME. The role of clusterin in tissue injury. Biochem Cell Biol. 1994;72:483-488.
42. Delaigue O, Arbeille B, Rossazza C, Lemesle M, Roingeard P. Quantitative analysis of immunogold labellings of collagen types I, III, IV and VI in healthy and pathological human corneas. Graefes Arch Clin Exp Ophthalmol. 1995;233:331-338.
43. Grässel S, Timpl R, Tan EM, Chu ML. Biosynthesis and processing of type XVI collagen in human fibroblasts and smooth muscle cells. Eur J Biochem. 1996;242:576-584.
44. Ratzinger S, Eble JA, Pasoldt A, et al. Collagen XVI induces formation of focal contacts on intestinal myofibroblasts isolated from the normal and inflamed intestinal tract. Matrix Biol. 2010;29:177-193.
45. Akagi A, Tajima S, Ishibashi A, Yamaguchi N, Nagai Y. Expression of type XVI collagen in human skin fibroblasts: enhanced expression in fibrotic skin diseases. J Invest Dermatol. 1999;113:246-250.
46. Bauer R, Ratzinger S, Wales L, et al. Inhibition of collagen XVI expression reduces glioma cell invasiveness. Cell Physiol Biochem. 2011;27:217-226.
47. Daniels MP. The role of agrin in synaptic development, plasticity and signaling in the central nervous system. Neurochem Int. 2012;61:848-853.
48. Kröger S, Horton SE, Honig LS. The developing avian retina expresses agrin isoforms during synaptogenesis. J Neurobiol. 1996;29:165-182.
49. Mazzon C, Anselmo A, Cibella J, et al. The critical role of agrin in the hematopoietic stem cell niche. Blood. 2011;118:2733-2742.
50. Zhang J, Wang Y, Chu Y, et al. Agrin is involved in lymphocytes activation that is mediated by alpha-dystroglycan. FASEB J. 2006;20:50-58.
51. VanSaun M, Werle MJ. Matrix metalloproteinase-3 removes agrin from synaptic basal lamina. J Neurobiol. 2000;43:140-149.
52. Patel TR, Butler G, McFarlane A, Xie I, Overall CM, Stetefeld J. Site specific cleavage mediated by MMPs regulates function of agrin. PLoS One. 2012;7:e43669.
53. Candiello J, Cole GJ, Halfter W. Age-dependent changes in the structure, composition and biophysical properties of a human basement membrane. Matrix Biol. 2010;29:402-410.
54. Keenan TD, Clark SJ, Unwin RD, Ridge LA, Day AJ, Bishop PN. Mapping the differential distribution of proteoglycan core proteins in the adult human retina, choroid, and sclera. Invest Ophthalmol Vis Sci. 2012;53:7528-7538.
55. To M, Goz A, Camenzind L, et al. Diabetes-induced morphological, biomechanical, and compositional changes in ocular basement membranes. Exp Eye Res. 2013;116:298-307.
56. Maritim AC, Sanders RA, Watkins JB III. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24-38.
57. Tidow H, Aperia A, Nissen P. How are ion pumps and agrin signaling integrated? Trends Biochem Sci. 2010;35:653-659.
58. Hilgenberg LG, Su H, Gu H, O'Dowd DK, Smith MA. Alpha3Na{thorn}/K{thorn}-ATPase is a neuronal receptor for agrin. Cell. 2006;125:359-369.